A. Kanchana
A. Kanchana has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anbazhagan. S
Sri Balaji Vidyapeeth, Department Of Surgical Oncology, Puducherry, India
1 shared publication - Joginder Joginder
School of Allied Health Sciences, Noida International University, Greater Noida, Uttar Pradesh, India
1 shared publication - K. V. Jamuna
Forensic Science, JAIN (Deemed-to-be University), Bangalore, Karnataka, India
1 shared publication Rashmitha Khilar
Department of Information Technology Saveetha School of Engineering Chennai Tamil Nadu India
1 shared publication- Satya Sundar Gajendra Mohapatra
Department of Radiology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
1 shared publication - Swarna Swetha Kolaventi
Atlas Skill Tech University uGDX School of Technology , Mumbai
1 shared publication
Latest Publications
- 25 March 2026
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (2) , e70028
A Robust Computational Framework for Autism Spectrum Disorder Identification Using Optimized Image Processing and Hybrid Learning Models
The classification of autism spectrum disorder (ASD) has reached a new stage of development that includes the former machine learning (ML) designs and image analysis designs. The study introduces a new framework that uses discrete wavelet transformation with Gaussian filter kernel (DWT‐GFK) to achieve the robust preprocessing of the image, including noise removal and preserving edges without affecting the quality of the image. The VGG16 deep learning model is used to extract features, elaborate visual patterns, and data features that are pertinent to the identification of ASD. The classification stage uses a family of Elevated Learning‐based Boosting Network with Hybrid Learning with Neural Classifier Logic (ELBN–HLNCL) that is optimized with the help of Walrus Optimization Algorithm (WaOA) to derive optimal model settings. Experimental testing of the proposed methods using the autism image dataset (AID), ASD screening dataset, and ABIDE dataset has shown the superiority of the proposed methodology with 99.95% accuracy, 99.9% recall, 99.8% precision, and 99.85% F 1‐score. The results demonstrate strong competitive performance compared with existing ASD classification approaches across multiple datasets. The findings offer promising applications in early ASD detection, facilitating improved diagnostic tools and aiding healthcare professionals in accurate assessments.
- 25 March 2026
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (2) , e70028
A Robust Computational Framework for Autism Spectrum Disorder Identification Using Optimized Image Processing and Hybrid Learning Models
The classification of autism spectrum disorder (ASD) has reached a new stage of development that includes the former machine learning (ML) designs and image analysis designs. The study introduces a new framework that uses discrete wavelet transformation with Gaussian filter kernel (DWT‐GFK) to achieve the robust preprocessing of the image, including noise removal and preserving edges without affecting the quality of the image. The VGG16 deep learning model is used to extract features, elaborate visual patterns, and data features that are pertinent to the identification of ASD. The classification stage uses a family of Elevated Learning‐based Boosting Network with Hybrid Learning with Neural Classifier Logic (ELBN–HLNCL) that is optimized with the help of Walrus Optimization Algorithm (WaOA) to derive optimal model settings. Experimental testing of the proposed methods using the autism image dataset (AID), ASD screening dataset, and ABIDE dataset has shown the superiority of the proposed methodology with 99.95% accuracy, 99.9% recall, 99.8% precision, and 99.85% F 1‐score. The results demonstrate strong competitive performance compared with existing ASD classification approaches across multiple datasets. The findings offer promising applications in early ASD detection, facilitating improved diagnostic tools and aiding healthcare professionals in accurate assessments.
- Open Access
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 533
Systematic Review of the Effectiveness of Mammography and Alternative Screening Methods in Breast Cancer Programs
Breast cancer is still one of the main reasons women get sick and die, which has brought a lot of attention to screening programs that try to find the disease early and increase survival rates. For a long time, mammography has been the usual way to check for breast cancer. However, it has some problems, like giving fake positives and negatives and not working as well in women with thick breast tissue. These problems have led to the search for other screening methods. This study looks at how well mammography and newer alternative screening methods find breast cancer. It looks at their pros and cons and how they might be able to improve current screening methods. Mammography is widely used, but it has been criticized for not being sensitive enough, especially in younger women and women with thicker breast tissue, where it may miss cancers or give false results that lead to tests that aren't needed. Even with these problems, mammography has been shown to lower the death rate from breast cancer in older women through regular screening, and it is still the gold standard in many national breast cancer programs. New options like ultrasound, MRI, DBT, and CEM show promise in making sensitivity and precision better. Ultrasound, especially when used with mammograms, can help find breast cancer in women with thick breasts, but the accuracy depends on how skilled the expert is. MRI is better at finding breast cancer, especially in people who are at a high risk, but it is more expensive and doesn't find as many cancers. This means that more false positives and needless treatments happen. Digital breast tomosynthesis (DBT) gives three-dimensional images, which compared to regular mammography increases the number of cancers found while decreasing the number of false positives and the need for follow-up images. Contrast-enhanced mammography (CEM), which combines the benefits of mammography with contrast agents, may help doctors make more accurate diagnoses, especially for women whose breast tissue is thick.
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 533
Open AccessSystematic Review of the Effectiveness of Mammography and Alternative Screening Methods in Breast Cancer Programs
Breast cancer is still one of the main reasons women get sick and die, which has brought a lot of attention to screening programs that try to find the disease early and increase survival rates. For a long time, mammography has been the usual way to check for breast cancer. However, it has some problems, like giving fake positives and negatives and not working as well in women with thick breast tissue. These problems have led to the search for other screening methods. This study looks at how well mammography and newer alternative screening methods find breast cancer. It looks at their pros and cons and how they might be able to improve current screening methods. Mammography is widely used, but it has been criticized for not being sensitive enough, especially in younger women and women with thicker breast tissue, where it may miss cancers or give false results that lead to tests that aren't needed. Even with these problems, mammography has been shown to lower the death rate from breast cancer in older women through regular screening, and it is still the gold standard in many national breast cancer programs. New options like ultrasound, MRI, DBT, and CEM show promise in making sensitivity and precision better. Ultrasound, especially when used with mammograms, can help find breast cancer in women with thick breasts, but the accuracy depends on how skilled the expert is. MRI is better at finding breast cancer, especially in people who are at a high risk, but it is more expensive and doesn't find as many cancers. This means that more false positives and needless treatments happen. Digital breast tomosynthesis (DBT) gives three-dimensional images, which compared to regular mammography increases the number of cancers found while decreasing the number of false positives and the need for follow-up images. Contrast-enhanced mammography (CEM), which combines the benefits of mammography with contrast agents, may help doctors make more accurate diagnoses, especially for women whose breast tissue is thick.